ProPhase Labs Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares ProPhase Labs Inc with three other
companies in this sector in UNITED STATES :
sales of $12.63 million
Rapid Micro Biosystems Inc
of which 68%
was Product & service revenue - recurring), and
of which 100%
was Pharmaceutical produc).
Sales were up sharply during the second
quarter of 2021 versus the previous year's second quarter.
During the second
quarter of 2021, sales at ProPhase Labs Inc totalled
an increase of 152.3%
from the $3.62 million in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled $24.41 million, which is
than through the first two quarters of 2020.
Sales at ProPhase Labs Inc appear to have some seasonality: during each of the previous 9
years, sales have been highest during the fourth quarter, which has accounted for
between 31.2% and 42.1%
of the annual
ProPhase Labs Inc reported sales of $14.51 million
December of 2020.
increase of 47.0%
versus 2019, when the company's sales were $9.88 million.